Medigus Ltd.
Symbol: MDGS
NASDAQ
2.745
USDMarket price today
-0.2062
P/E Ratio
-0.0022
PEG Ratio
4.67M
MRK Cap
- 0.00%
DIV Yield
Medigus Ltd. (MDGS) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 79.33 | 25.1 | 27.3 | 22.4 | ||||||||||
balance-sheet.row.short-term-investments | 8.11 | 5 | 3.3 | 0 | ||||||||||
balance-sheet.row.net-receivables | 94.87 | 25.2 | 1.7 | 0.3 | ||||||||||
balance-sheet.row.inventory | 8.67 | 1.8 | 1.2 | 0.2 | ||||||||||
balance-sheet.row.other-current-assets | 21.11 | 0.2 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.total-current-assets | 197.6 | 52.3 | 31.7 | 24 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 3.82 | 1 | 0.1 | 0.4 | ||||||||||
balance-sheet.row.goodwill | 36.23 | 9.1 | 0.9 | 0.3 | ||||||||||
balance-sheet.row.intangible-assets | 87.71 | 21.8 | 7.4 | 0.5 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 123.94 | 30.9 | 8.3 | 0.5 | ||||||||||
balance-sheet.row.long-term-investments | 39.56 | 13.1 | 18.8 | 6.2 | ||||||||||
balance-sheet.row.tax-assets | 0.85 | 0.4 | 0 | 0 | ||||||||||
balance-sheet.row.other-non-current-assets | -83.66 | 0 | 0.8 | 1.2 | ||||||||||
balance-sheet.row.total-non-current-assets | 168.18 | 45.4 | 28.1 | 8.3 | ||||||||||
balance-sheet.row.other-assets | 0.85 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 366.64 | 97.7 | 59.7 | 32.3 | ||||||||||
balance-sheet.row.account-payables | 78.02 | 20.4 | 0.7 | 0.1 | ||||||||||
balance-sheet.row.short-term-debt | 14.76 | 6.7 | 0.9 | 0.1 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 12.98 | 3.4 | 0.7 | 0 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 2.6 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3.56 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 49.74 | 10.4 | 4.9 | 3.2 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 16.68 | 5.3 | 1.7 | 2.6 | ||||||||||
balance-sheet.row.other-liabilities | 4.67 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 1.25 | 0.6 | 0 | 0.1 | ||||||||||
balance-sheet.row.total-liab | 168.36 | 43 | 8.3 | 6.1 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 93 | ||||||||||
balance-sheet.row.retained-earnings | -358.74 | -85.6 | -74.2 | -81 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 26.97 | 13.2 | 12.6 | 10.7 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 473.58 | 111.5 | 110.8 | 0.2 | ||||||||||
balance-sheet.row.total-stockholders-equity | 141.81 | 39.1 | 49.2 | 23 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 183.32 | 97.7 | 59.7 | 32.3 | ||||||||||
balance-sheet.row.minority-interest | 56.46 | 15.5 | 2.2 | 3.2 | ||||||||||
balance-sheet.row.total-equity | 198.27 | 54.7 | 51.4 | 26.2 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 183.32 | - | - | - | ||||||||||
Total Investments | 47.67 | 18.1 | 22.2 | 6.2 | ||||||||||
balance-sheet.row.total-debt | 21.73 | 10.1 | 1.6 | 0.1 | ||||||||||
balance-sheet.row.net-debt | -43.12 | -9.9 | -22.4 | -22.3 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -21.79 | -10.1 | 4.2 | -6.8 | |||||||||||
cash-flows.row.depreciation-and-amortization | 5.1 | 3.2 | 0.3 | 0.2 | |||||||||||
cash-flows.row.deferred-income-tax | -5.51 | 0.4 | -12.8 | -1.1 | |||||||||||
cash-flows.row.stock-based-compensation | 0.63 | 0.8 | 2.4 | 1.4 | |||||||||||
cash-flows.row.change-in-working-capital | -2.08 | -1.1 | 0.1 | -0.3 | |||||||||||
cash-flows.row.account-receivables | -3.62 | -7.8 | -0.2 | -0.1 | |||||||||||
cash-flows.row.inventory | -1.09 | -0.6 | -0.6 | -0.5 | |||||||||||
cash-flows.row.account-payables | 3.64 | 5.8 | 1 | 0.1 | |||||||||||
cash-flows.row.other-working-capital | -1.01 | 1.4 | -0.1 | 0.2 | |||||||||||
cash-flows.row.other-non-cash-items | 14.17 | 1.2 | 0.6 | 0.5 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -9.5 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1.8 | -0.1 | -0.1 | -0.3 | |||||||||||
cash-flows.row.acquisitions-net | -2.92 | -2.4 | -7.7 | -1.3 | |||||||||||
cash-flows.row.purchases-of-investments | -2.86 | -6.6 | -0.2 | -1.8 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 1.24 | 0.5 | 1.9 | 3.1 | |||||||||||
cash-flows.row.other-investing-activites | -5.45 | 4.1 | -6.2 | -1.3 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -11.79 | -4.5 | -12.4 | -1.6 | |||||||||||
cash-flows.row.debt-repayment | -3.32 | -4.7 | -1.5 | 0 | |||||||||||
cash-flows.row.common-stock-issued | 13.25 | 12.6 | 18.7 | 23 | |||||||||||
cash-flows.row.common-stock-repurchased | -2.38 | 0 | 0 | -22.9 | |||||||||||
cash-flows.row.dividends-paid | -7.11 | -4.2 | 0 | -0.1 | |||||||||||
cash-flows.row.other-financing-activites | 1.72 | 1.8 | 1.9 | 0.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5.18 | 5.4 | 19.1 | 22.9 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.88 | 0.8 | 0.2 | 0.1 | |||||||||||
cash-flows.row.net-change-in-cash | -14.71 | -4 | 1.7 | 15.3 | |||||||||||
cash-flows.row.cash-at-end-of-period | 50.04 | 20.1 | 24 | 22.4 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 64.75 | 24 | 22.4 | 7 | |||||||||||
cash-flows.row.operating-cash-flow | -9.5 | -5.7 | -5.3 | -6.1 | |||||||||||
cash-flows.row.capital-expenditure | -1.8 | -0.1 | -0.1 | -0.3 | |||||||||||
cash-flows.row.free-cash-flow | -11.29 | -5.7 | -5.4 | -6.5 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 166.86 | 91.9 | 10.1 | 0.5 | |||||||||||
income-statement-row.row.cost-of-revenue | 141.96 | 77.4 | 5.3 | 1 | |||||||||||
income-statement-row.row.gross-profit | 24.9 | 14.5 | 4.8 | -0.5 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 8.23 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 16.81 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3.76 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0.5 | 0 | |||||||||||
income-statement-row.row.operating-expenses | 40.69 | 23 | 13 | 7 | |||||||||||
income-statement-row.row.cost-and-expenses | 182.65 | 100.4 | 18.3 | 8 | |||||||||||
income-statement-row.row.interest-income | 2.49 | 2.3 | 0.3 | 0.2 | |||||||||||
income-statement-row.row.interest-expense | 2.53 | -4.1 | 0.3 | 0 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3.76 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | -5.75 | 3.7 | 12.3 | 0.5 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0.5 | 0 | |||||||||||
income-statement-row.row.total-operating-expenses | -5.75 | 3.7 | 12.3 | 0.5 | |||||||||||
income-statement-row.row.interest-expense | 2.53 | -4.1 | 0.3 | 0 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 5.1 | 1.8 | -14 | -0.5 | |||||||||||
income-statement-row.row.ebitda-caps | -9.36 | - | - | - | |||||||||||
income-statement-row.row.operating-income | -14.45 | -13.8 | -8.2 | -7.4 | |||||||||||
income-statement-row.row.income-before-tax | -20.2 | -10.1 | 4.2 | -6.8 | |||||||||||
income-statement-row.row.income-tax-expense | 0.42 | 0.1 | 0.1 | 0 | |||||||||||
income-statement-row.row.net-income | -21.79 | -10.2 | 4 | -6.8 |
Frequently Asked Question
What is Medigus Ltd. (MDGS) total assets?
Medigus Ltd. (MDGS) total assets is 97651000.000.
What is enterprise annual revenue?
The annual revenue is 80077500.000.
What is firm profit margin?
Firm profit margin is 0.150.
What is company free cash flow?
The free cash flow is -5.754.
What is enterprise net profit margin?
The net profit margin is -0.135.
What is firm total revenue?
The total revenue is -0.086.
What is Medigus Ltd. (MDGS) net profit (net income)?
The net profit (net income) is -10208000.000.
What is firm total debt?
The total debt is 10135000.000.
What is operating expences number?
The operating expences are 23033000.000.
What is company cash figure?
Enretprise cash is 12359000.000.